Answers are grounded in this paper and cite their sources.
Preclinical evaluation assesses onco-virotherapy via tumoroids, highlighting dual oncolytic and immunostimulatory discovery mechanisms.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lê et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: